Regulation Solvency II, Risk-based capital, Accounting/Tax

Analysis

Swiss Re's Dan Ryan: UK moratorium on genetic testing will have to change

Dan Ryan, head of research at the Swiss Re Institute, talks to Cintia Cheong about the rise of genetic testing, life insurtech, and why insurers and academics need to work together to understand mortality trends

Justice Committee's Ogden advice raises fear of further delay

MPs have told the government it must face the "real world" when implementing the new personal injury discount rate. But its recommendations may cause more delay to the process, and pain for insurers as the industry tussles with making appropriate assumptions. Paul Walsh reports

Economic capital: the solution to two big insurance problems

Using economic capital metrics makes for better business decisions and improves the wider understanding of profitability in the insurance sector. The opportunity is not to be missed, argue Gez Llanaj and Assad Shah

Eiopa's Fausto Parente: convergence is the remedy for regulatory arbitrage

The executive director of the EU's insurance authority discusses its new powers, Brexit, supervisory convergence, insurtech and sustainability in this interview with Christopher Cundy

Insurers downbeat on proposed Solvency II reforms

Eiopa has completed its first major review of Solvency II and, on the biggest issues, its proposals have not gone down well. Christopher Cundy reports

A transparent approach to the SFCR

Denmark’s Industriens Pensionsforsikring went the extra mile in completing its solvency and financial condition report (SFCR), providing historical data and putting the quantitative information into context. David Walker asks chief risk officer Pernille Jul Overby why she opted for more work